title: Treatment adherence in individuals with rapid cycling bipolar disorder: results from a clinical-trial setting.
authors.forename: Martha
authors.initials: M
authors.lastname: Sajatovic
authors.forename: Omar
authors.initials: O
authors.lastname: Elhaj
authors.forename: Eric A
authors.initials: EA
authors.lastname: Youngstrom
authors.forename: Sarah R
authors.initials: SR
authors.lastname: Bilali
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Rapport
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Ganocy
authors.forename: Joseph R
authors.initials: JR
authors.lastname: Calabrese
mesh_terms: D000328:Adult; D018692:Antimanic Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000523:psychology; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D000077213:Lamotrigine; D018020:Lithium Compounds / Q000627:therapeutic use; D008297:Male; D010349:Patient Compliance; D011569:Psychiatric Status Rating Scales; D014227:Triazines / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use
chemical_list: D018692:Antimanic Agents; D018020:Lithium Compounds; D014227:Triazines; D014635:Valproic Acid; D000077213:Lamotrigine